|
1
|
Compston JE, McClung MR and Leslie WD:
Osteoporosis. Lancet. 393:364–376. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cheung WH, Miclau T, Chow SK, Yang FF and
Alt V: Fracture healing in osteoporotic bone. Injury. 47 (Suppl
2):S21–S26. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Khosla S and Hofbauer LC: Osteoporosis
treatment: Recent developments and ongoing challenges. Lancet
Diabetes Endocrinol. 5:898–907. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Larsson S and Fazzalari NL:
Anti-osteoporosis therapy and fracture healing. Arch Orthop Trauma
Surg. 134:291–297. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hegde V, Jo JE, Andreopoulou P and Lane
JM: Effect of osteoporosis medications on fracture healing.
Osteoporosis Int. 27:861–871. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ha KY, Park KS, Kim SI and Kim YH: Does
bisphosphonate-based anti-osteoporosis medication affect
osteoporotic spinal fracture healing? Osteoporosis Int. 27:483–488.
2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Silverman SL, Kupperman ES and Bukata SV:
Members of IOFFWG. Fracture healing: A consensus report from the
International Osteoporosis Foundation Fracture Working Group.
Osteoporosis Int. 27:2197–2206. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Cosman F, de Beur SJ, LeBoff MS, Lewiecki
EM, Tanner B, Randall S and Lindsay R: National Osteoporosis
Foundation. Clinician's guide to prevention and treatment of
osteoporosis. Osteoporosis Int. 25:2359–2381. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Compston J, Cooper A, Cooper C, Francis R,
Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P and Wilkins M:
National Osteoporosis Guideline Group (NOGG). Guidelines for the
diagnosis and management of osteoporosis in postmenopausal women
and men from the age of 50 years in the UK. Maturitas. 62:105–108.
2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lin J, Zhu J, Wang Y, Zhang N, Gober HJ,
Qiu X, Li D and Wang L: Chinese single herbs and active ingredients
for postmenopausal osteoporosis: From preclinical evidence to
action mechanism. Biosci Trends. 11:496–506. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Leung PC and Siu WS: Herbal treatment for
osteoporosis: A current review. J Tradit Complement Med. 3:82–87.
2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Salari Sharif P, Nikfar S and Abdollahi M:
Prevention of bone resorption by intake of phytoestrogens in
postmenopausal women: A meta-analysis. Age (Dordr). 33:421–431.
2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lim SH, Ha TY, Ahn J and Kim S: Estrogenic
activities of Psoralea corylifolia L. seed extracts and main
constituents. Phytomedicine. 18:425–430. 2011.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tang DZ, Yang F, Yang Z, Huang J, Shi Q,
Chen D and Wang YJ: Psoralen stimulates osteoblast differentiation
through activation of BMP signaling. Biochem Biophys Res Commun.
405:256–261. 2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yang Z, Huang JH, Liu SF, Zhao YJ, Shen
ZY, Wang YJ and Bian Q: The osteoprotective effect of psoralen in
ovariectomy-induced osteoporotic rats via stimulating the
osteoblastic differentiation from bone mesenchymal stem cells.
Menopause. 19:1156–1164. 2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yuan X, Bi Y, Yan Z, Pu W, Li Y and Zhou
K: Psoralen and isopsoralen ameliorate sex hormone
deficiency-induced osteoporosis in female and male mice. BioMed Res
Int. 2016(6869452)2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Xin D, Wang H, Yang J, Su YF, Fan GW, Wang
YF, Zhu Y and Gao XM: Phytoestrogens from Psoralea
corylifolia reveal estrogen receptor-subtype selectivity.
Phytomedicine. 17:126–131. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Thulin JD, Bradfield JF, Bergdall VK,
Conour LA, Grady AW, Hickman DL, Norton JN and Wallace JM: The cost
of self-imposed regulatory burden in animal research. FASEB J.
28:3297–3300. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bouxsein ML, Boyd SK, Christiansen BA,
Guldberg RE, Jepsen KJ and Muller R: Guidelines for assessment of
bone microstructure in rodents using micro-computed tomography. J
Bone Miner Res. 25:1468–1486. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Naik AA, Xie C, Zuscik MJ, Kingsley P,
Schwarz EM, Awad H, Guldberg R, Drissi H, Puzas JD, Boyce B, et al:
Reduced COX-2 expression in aged mice is associated with impaired
fracture healing. J Bone Miner Res. 24:251–264. 2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ng JJ, Wei Y, Zhou B, Bernhard J, Robinson
S, Burapachaisri A, Guo XE and Vunjak-Novakovic G: Recapitulation
of physiological spatiotemporal signals promotes in vitro formation
of phenotypically stable human articular cartilage. Proc Natl Acad
Sci USA. 114:2556–2561. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Jia M, Nie Y, Cao DP, Xue YY, Wang JS,
Zhao L, Rahman K, Zhang QY and Qin LP: Potential antiosteoporotic
agents from plants: A comprehensive review. Evid Based Complement
Alternat Med. 2012(364604)2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wong RW and Rabie AB: Effect of psoralen
on bone formation. J Orthop Res. 29:158–164. 2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chen L, Jiang W, Huang J, He BC, Zuo GW,
Zhang W, Luo Q, Shi Q, Zhang BQ, Wagner ER, et al: Insulin-like
growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic
differentiation and bone formation. J Bone Miner Res. 25:2447–2459.
2010.PubMed/NCBI View
Article : Google Scholar
|
|
25
|
Huang K, Wu G, Zou J and Peng S:
Combination therapy with BMP-2 and psoralen enhances fracture
healing in ovariectomized mice. Exp Ther Med. 16:1655–1662.
2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Khosla S, Oursler MJ and Monroe DG:
Estrogen and the skeleton. Trends Endocrinol Metab. 23:576–581.
2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wilkinson HN and Hardman MJ: The role of
estrogen in cutaneous ageing and repair. Maturitas. 103:60–64.
2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chow SK, Leung KS, Qin L, Wei F and Cheung
WH: Callus formation is related to the expression ratios of
estrogen receptors-alpha and -beta in ovariectomy-induced
osteoporotic fracture healing. Arch Orthop Trauma Surg.
134:1405–1416. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Sirotkin AV and Harrath AH: Phytoestrogens
and their effects. Eur J Pharmacol. 741:230–236. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lagari VS and Levis S: Phytoestrogens in
the prevention of postmenopausal bone loss. J Clin Densitom.
16:445–449. 2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhao PW, Niu JZ, Wang JF and Wang LQ:
Research on phytoestrogenic effects and its mechanism of psoralen.
Zhongguo Zhong Yao Za Zhi. 33:59–63. 2008.PubMed/NCBI(In Chinese).
|
|
32
|
Soto AM, Murai JT, Siiteri PK and
Sonnenschein C: Control of cell proliferation: Evidence for
negative control on estrogen-sensitive T47D human breast cancer
cells. Cancer Res. 46:2271–2275. 1986.PubMed/NCBI
|
|
33
|
Catalano A, Loddo S, Bellone F, Pecora C,
Lasco A and Morabito N: Pulsed electromagnetic fields modulate bone
metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with
postmenopausal osteoporosis: A pilot study. Bone. 116:42–46.
2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Gerstenfeld LC, Sacks DJ, Pelis M, Mason
ZD, Graves DT, Barrero M, Ominsky MS, Kostenuik PJ, Morgan EF and
Einhorn TA: Comparison of effects of the bisphosphonate alendronate
versus the RANKL inhibitor denosumab on murine fracture healing. J
Bone Miner Res. 24:196–208. 2009.PubMed/NCBI View Article : Google Scholar
|
